Most Recent
After 7 years of litigation, patent for blockbuster sleep drug Circadin found valid
Intellectual Property 2024-04-18 11:21 pm By Sam Matthews

After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Crypto gambling site Stake.com fights TM suit over Aussie launch
Intellectual Property 2023-10-04 2:02 pm By Cindy Cameronne

Global cryptocurrency and gambling website Stake.com is fighting to strike out claims in a lawsuit by Sydney-based online investment platform Stake over a planned Australian […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

High Court won’t step in to revive Energy Beverages’ ‘Motherland’ trade mark
Intellectual Property 2023-09-18 11:11 pm By Cat Fredenburgh

The maker of Mother Energy drinks has failed to convince the High Court that it should weigh in on its long-running intellectual property spat with […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Lights out on Hanhwa’s solar cell patent infringement suit
Intellectual Property 2023-09-01 11:57 pm By Christine Caulfield

A solar cell patent at the heart of intellectual property litigation brought by South Korean technology giant Hanwha has been found invalid. Hanwha lost its […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Optus to rebrand ‘Boost’ products in trade mark case settlement
Telecommunications 2023-06-14 4:46 pm By Christine Caulfield

Optus has agreed to rebrand products that Boost Tel claimed had infringed on its trade marks, in a settlement of the rivals’ intellectual property spat. […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Facebook ad shows use of ‘Motherland’ trade mark, High Court told
High Court 2023-04-24 10:55 pm By Cindy Cameronne

The High Court has been asked to weigh in on whether online ads targeting Australian consumers can be the basis for a trade mark registration, […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Drink rivals mull High Court appeals after losing ‘Mother’ of all trade mark disputes
Intellectual Property 2023-03-22 2:11 pm By Cindy Cameronne

The owners of Mother energy drinks and Vittoria Food & Beverage have lost their challenges to each other’s ‘Motherland’ and ‘Mothersky’ trade marks and are […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Optus ‘Boost’ promotions halted as Boost Tel lawsuit plays out
Intellectual Property 2023-03-16 4:31 pm By Sam Matthews

Telecommunications giant Singtel Optus has been barred from promoting various products using the word ‘boost’ until an intellectual property suit brought by Boost Mobile is […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Boost Mobile sues Optus for ‘flagrant’ trade mark infringement
Intellectual Property 2023-03-01 4:40 pm By Cindy Cameronne

Boost Mobile has sued telecommunications giant Singtel Optus, alleging it “misappropriated” its goodwill by marketing services under a similar product name after Boost chose to […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Biogen, Pharmacor lay down swords in battle over MS drug patent
Intellectual Property 2022-10-31 11:01 pm By Cat Fredenburgh

Swiss pharmaceutical company Biogen and Australian generic drug maker Pharmacor have dropped their claims against one another in a lawsuit over the patent for MS […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.